These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 21406335)

  • 1. miRNA expression profiling of mycosis fungoides.
    van Kester MS; Ballabio E; Benner MF; Chen XH; Saunders NJ; van der Fits L; van Doorn R; Vermeer MH; Willemze R; Tensen CP; Lawrie CH
    Mol Oncol; 2011 Jun; 5(3):273-80. PubMed ID: 21406335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant microRNA expression in tumor mycosis fungoides.
    Papadavid E; Braoudaki M; Bourdakou M; Lykoudi A; Nikolaou V; Tounta G; Ekonomidi A; Athanasiadis E; Spyrou G; Antoniou C; Kitsiou-Tzeli S; Rigopoulos D; Kolialexi A
    Tumour Biol; 2016 Nov; 37(11):14667-14675. PubMed ID: 27623940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary cutaneous anaplastic large cell lymphoma shows a distinct miRNA expression profile and reveals differences from tumor-stage mycosis fungoides.
    Benner MF; Ballabio E; van Kester MS; Saunders NJ; Vermeer MH; Willemze R; Lawrie CH; Tensen CP
    Exp Dermatol; 2012 Aug; 21(8):632-4. PubMed ID: 22776000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic imbalances and microRNA transcriptional profiles in patients with mycosis fungoides.
    Garaicoa FH; Roisman A; Arias M; Trila C; Fridmanis M; Abeldaño A; Vanzulli S; Narbaitz M; Slavutsky I
    Tumour Biol; 2016 Oct; 37(10):13637-13647. PubMed ID: 27473081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycosis fungoides progression could be regulated by microRNAs.
    Manso R; Martínez-Magunacelaya N; Eraña-Tomás I; Monsalvez V; Rodríguez-Peralto JL; Ortiz-Romero PL; Santonja C; Cristóbal I; Piris MA; Rodríguez-Pinilla SM
    PLoS One; 2018; 13(6):e0198477. PubMed ID: 29894486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA expression in early mycosis fungoides is distinctly different from atopic dermatitis and advanced cutaneous T-cell lymphoma.
    Ralfkiaer U; Lindahl LM; Litman T; Gjerdrum LM; Ahler CB; Gniadecki R; Marstrand T; Fredholm S; Iversen L; Wasik MA; Bonefeld CM; Geisler C; Krejsgaard T; Glue C; Røpke MA; Woetmann A; Skov L; Grønbæk K; Odum N
    Anticancer Res; 2014 Dec; 34(12):7207-17. PubMed ID: 25503151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The MicroRNA Expression Profile Differs Between Erythrodermic Mycosis Fungoides and Sézary Syndrome.
    Rittig AH; Lindahl LM; Johansen C; Celis P; Ødum N; Iversen L; Litman T
    Acta Derm Venereol; 2019 Nov; 99(12):1148-1153. PubMed ID: 31453630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppressed microRNA-195-5p expression in mycosis fungoides promotes tumor cell proliferation.
    Rittig AH; Johansen C; Celis P; Odum N; Litman T; Woetmann A; Lindahl LM; Iversen L
    Exp Dermatol; 2021 Aug; 30(8):1141-1149. PubMed ID: 32492224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered microRNA expression in folliculotropic and transformed mycosis fungoides.
    Marosvári D; Téglási V; Csala I; Marschalkó M; Bödör C; Timár B; Csomor J; Hársing J; Reiniger L
    Pathol Oncol Res; 2015 Jul; 21(3):821-5. PubMed ID: 25698383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic miRNA classifier in early-stage mycosis fungoides: development and validation in a Danish nationwide study.
    Lindahl LM; Besenbacher S; Rittig AH; Celis P; Willerslev-Olsen A; Gjerdrum LMR; Krejsgaard T; Johansen C; Litman T; Woetmann A; Odum N; Iversen L
    Blood; 2018 Feb; 131(7):759-770. PubMed ID: 29208599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-155 is involved in tumor progression of mycosis fungoides.
    Moyal L; Barzilai A; Gorovitz B; Hirshberg A; Amariglio N; Jacob-Hirsch J; Maron L; Feinmesser M; Hodak E
    Exp Dermatol; 2013 Jun; 22(6):431-3. PubMed ID: 23711069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogenomic analysis of mycosis fungoides reveals major differences with Sezary syndrome.
    van Doorn R; van Kester MS; Dijkman R; Vermeer MH; Mulder AA; Szuhai K; Knijnenburg J; Boer JM; Willemze R; Tensen CP
    Blood; 2009 Jan; 113(1):127-36. PubMed ID: 18832135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miRNA Signature in Early-stage Mycosis Fungoides.
    Sørensen ST; Litman T; Gluud M; Celis P; Torres-Rusillo S; Willerslev-Olsen A; Ødum N; Iversen L; Lindahl LM
    Acta Derm Venereol; 2022 Oct; 102():adv00785. PubMed ID: 35788691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stage-dependent Increase in Expression of miR-155 and Ki-67 and Number of Tumour-associated Inflammatory Cells in Folliculotropic Mycosis Fungoides.
    Atzmony L; Moyal L; Feinmesser M; Gorovitz B; Hirshberg A; Amitay-Laish I; Prag-Naveh H; Barzilai A; Hodak E
    Acta Derm Venereol; 2020 Aug; 100(15):adv00230. PubMed ID: 32556361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of c-myb in leukaemic and non-leukaemic variants of cutaneous T-cell lymphoma.
    Poenitz N; Simon-Ackermann J; Gratchev A; Qadoumi M; Klemke CD; Stadler R; Kremer A; Radenhausen M; Henke U; Assaf C; Utikal J; Goerdt S; Dippel E
    Dermatology; 2005; 211(2):84-92. PubMed ID: 16088151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of clonal T-cell receptor gamma gene rearrangements in early mycosis fungoides/Sezary syndrome by polymerase chain reaction and denaturing gradient gel electrophoresis (PCR/DGGE).
    Wood GS; Tung RM; Haeffner AC; Crooks CF; Liao S; Orozco R; Veelken H; Kadin ME; Koh H; Heald P
    J Invest Dermatol; 1994 Jul; 103(1):34-41. PubMed ID: 8027579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unilesional mycosis fungoides is associated with increased expression of microRNA-17~92 and T helper 1 skewing.
    Moyal L; Gorovitz-Haris B; Yehezkel S; Jacob-Hirsch J; Bershtein V; Barzilai A; Rotem C; Sherman S; Amitay-Laish I; Feinmesser M; Hodak E
    Br J Dermatol; 2019 May; 180(5):1123-1134. PubMed ID: 30431147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microarray analysis of microRNA expression in cutaneous squamous cell carcinoma.
    Sand M; Skrygan M; Georgas D; Sand D; Hahn SA; Gambichler T; Altmeyer P; Bechara FG
    J Dermatol Sci; 2012 Dec; 68(3):119-26. PubMed ID: 23026055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA expression in Sezary syndrome: identification, function, and diagnostic potential.
    Ballabio E; Mitchell T; van Kester MS; Taylor S; Dunlop HM; Chi J; Tosi I; Vermeer MH; Tramonti D; Saunders NJ; Boultwood J; Wainscoat JS; Pezzella F; Whittaker SJ; Tensen CP; Hatton CS; Lawrie CH
    Blood; 2010 Aug; 116(7):1105-13. PubMed ID: 20448109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential role for microRNA-16 (miR-16) and microRNA-93 (miR-93) in diagnosis and prediction of disease progression in mycosis fungoides in Egyptian patients.
    Talaat IM; Abdelmaksoud RE; Guimei M; Agamia NF; Nugud A; El-Serafi AT
    PLoS One; 2019; 14(10):e0224305. PubMed ID: 31648231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.